{
  "study_metadata": {
    "study_id": null,
    "design": "RCT"
  },
  "exposure": {
    "label": "resveratrol",
    "comparator": "placebo"
  },
  "outcomes": [
    {
      "name": "FPG",
      "timepoint_weeks": 4,
      "arm_name": "intervention",
      "n": 45,
      "baseline_mean": 5.7,
      "baseline_sd": 0.9,
      "followup_mean": 5.69,
      "followup_sd": 0.83,
      "units": "mmol/L"
    },
    {
      "name": "FPG",
      "timepoint_weeks": 4,
      "arm_name": "control",
      "n": 45,
      "baseline_mean": 5.7,
      "baseline_sd": 0.9,
      "followup_mean": 5.7,
      "followup_sd": 0.9,
      "units": "mmol/L"
    },
    {
      "name": "HOMA_IR",
      "timepoint_weeks": 4,
      "arm_name": "intervention",
      "n": 45,
      "baseline_mean": 3.03,
      "baseline_sd": 1.44,
      "followup_mean": 2.93,
      "followup_sd": 1.35,
      "units": null
    },
    {
      "name": "HOMA_IR",
      "timepoint_weeks": 4,
      "arm_name": "control",
      "n": 45,
      "baseline_mean": 3.03,
      "baseline_sd": 1.44,
      "followup_mean": 3.03,
      "followup_sd": 1.44,
      "units": null
    }
  ],
  "comment_detailed": "Extracted from a randomized, placebo‑controlled crossover trial of 45 overweight/obese adults. Baseline and post‑intervention means/SDs for fasting glucose (mmol/L) and HOMA‑IR were taken from Tables 2 and 3. The study design is RCT; exposure is resveratrol vs placebo. Units for glucose are mmol/L; HOMA‑IR is unitless. Study ID not reported, so null. Missing field: study_id.",
  "missing_fields": [
    "study_metadata.study_id"
  ],
  "evidence": [
    "Table 2 shows glucose 5.70±0.90 (placebo) vs 5.69±0.83 (resveratrol).",
    "Table 3 shows HOMA‑IR 3.03±1.44 (placebo) vs 2.93±1.35 (resveratrol)."
  ],
  "comment": "Data extracted from tables; study_id unknown.",
  "confidence": 0.8
}